YVETTE BALZANO: Open Payments
NPI 1134811482 · POINT PLEASANT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,267 in 138 payments from 14 companies in 2025. Trend: 2023 $357 · 2024 $1,258 · 2025 $2,267
Food & beverage: $2,155Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 16 | $331 |
| Lundbeck LLC | 19 | $310 |
| Otsuka America Pharmaceutical, Inc. | 21 | $296 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $256 |
| Tris Pharma Inc | 15 | $246 |
| ABBVIE INC. | 22 | $237 |
| Bausch Health US, LLC | 9 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $104 |
| Janssen Pharmaceuticals, Inc | 5 | $100 |
| Vanda Pharmaceuticals Inc. | 5 | $87 |
Products named: REXULTI, CAPLYTA, Dyanavel XR, VRAYLAR, AUSTEDO XR, WELLBUTRIN, TRINTELLIX, FANAPT.
Industry payments across NJ — which companies pay providers there.
